DRW Securities’s BioNTech BNTX Stock Holding History

DRW Securities’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,800	Closed	-$1.5M	–	257
2022 Q1	$1.5M	Buy	+8,800	New	+$1.48M	0.04%	109

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

DRW Securities's BNTX Position: Q3 2023 in Review

DRW Securities sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 2,000 shares — an estimated $216K sold.

DRW Securities first reported a position in BNTX in Q2 2021 and held it in 2 quarters. The position peaked at $940K in Q2 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

DRW Securities reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
DRW Securities sold 2,000 BioNTech shares in Q3 2023, an estimated $216K.
DRW Securities first reported a position in BioNTech in Q2 2021 and held it in 2 quarters.
DRW Securities's BioNTech position peaked at $940K in Q2 2021.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on DRW Securities's 13F filing for Q3 2023, filed 13 Nov 2023.